91 results
Page 2 of 5
8-K
EX-99.1
83dn cw40weh
6 Jun 23
Regulation FD Disclosure
8:00am
8-K
EX-99.1
u82tgj 3l
4 May 23
Novocure Reports First Quarter 2023 Financial Results
7:02am
8-K
EX-99.1
4wytdm2uki0mx
26 Apr 23
Regulation FD Disclosure
10:03am
8-K
EX-99.1
t6lgxo4iozep
27 Oct 22
Novocure Reports Third Quarter 2022 Financial Results
7:20am
8-K
EX-99.1
63jd83skjup0owv 9ors
28 Jul 22
Novocure Reports Second Quarter 2022 Financial Results
7:03am
8-K
EX-99.1
movhr2trgq0444roqh6
3 Jun 22
Regulation FD Disclosure
8:01am
8-K
EX-10.1
tda6vnk0rcb urp
26 May 22
Entry into a Material Definitive Agreement
8:04am
8-K
EX-99.1
kbg2m
26 May 22
Entry into a Material Definitive Agreement
8:04am
8-K
EX-99.1
g6pod5vl4pa5ltteo9
28 Apr 22
Novocure Reports First Quarter 2022 Financial Results
7:04am
8-K
EX-99.1
pk8huxij7
23 Mar 22
Novocure Announces Favorable Recommendation to Continue the Phase 3 Pivotal INNOVATE-3 Study of Tumor Treating Fields in Ovarian Cancer
8:01am
8-K
EX-99.1
k7hxjkt9dsnh
24 Feb 22
Novocure Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Company Update
7:00am